Myasthenia Gravis

What is Myasthenia Gravis?

Myasthenia Gravis is a chronic autoimmune condition affecting skeletal muscles of the body characterized by progression degeneration of the voluntary muscles becoming weak and functionally useless in some of the important muscles of the eyes and face. In Myasthenia Gravis faulty antibodies are responsible for destroying or blocking receptor sites for the chemical acetylcholine, which is necessary for the muscle fiber to pass information to different muscles. Current traditional treatments are steroidal which in long term use these chemicals can have deleterious effects and the benefit of alternative treatments present less risk.

Stem cells are the cells responsible for developing an entire human body from a two-celled embryo; due to their unlimited divisions and ability to differentiate into different cell lineages. Stem cells have been harnessed by technology to isolate them outside the human body, concentrate them and implant them back into the body. Mesenchymal stem cells are known to have angiogenic, trans differentiation and homing properties which are useful for forming new blood vessels, differentiating into required targeted cells and creating a microenvironment for the faster secretion of immune cells.

Treatment of Myasthenia Gravis at Cellebration Life Sciences, Inc.

At Cellebration, we have mastered the technology for isolating the maximum number of viable stem cells from either the autologous sources of your own body or allogeneic with the matched donor to treat various patients with Scleroderma.  We are a licensed, private organization with a highly technologically equipped specialized facility under development designed to isolate and enrich the viable cell stems which will be infused into the patient. These cells are administered through one of two methods after a considerable analysis of the patient’s unique history and medical professional’s advice.

  • Sub-Cutaneous Administration: – In this mode; stem cells can as well be administered in the fat layer of the skin. They can help regenerate cells, promote restructuring of tissues.
  • Intravenous Administration: – In this mode, cells are infused into the peripheral veins to expand blood volumes in the central nervous system, to ensure that the maximum number of cells are reaching the targeted area.

Infused into the body, these cells can repopulate the damaged parts of the organ. Through paracrine effects they differentiate into the damaged cells to restore function and continue to regulate the immune system and promote hormonal balance. These cells can regulate the immune system and reduce the impact of autoimmune disorders. As shown in worldwide studies there is a considerable decrease in the antibodies against acetylcholine receptors after stem cell treatment was administered. Thus, with our highly specialized approach, it is now possible to obtain noticeable improvements in patients with Myasthenia Gravis, within the symptoms as well as improving functional abilities.